img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
November 29, 2023
img
img
Treasure Global Inc
(Nasdaq: TGL)

$4,000,000

Underwritten Public Offering
Sole Bookrunner

November 16, 2023
img
img
HNR Acquisition Corp. Merger with Pogo Resources, LLC
(Nasdaq: HNRA)

~$90,000,000

Business Combination
Capital Markets Advisor

November 13, 2023
img
img
LQR House Inc.
(Nasdaq: LQR)

$12,650,000

Underwritten Public Offering
Sole Bookrunner

November 9, 2023
img
img
AI Transportation Acquisition Corp
(Nasdaq: AITRU)

$60,000,000

SPAC Initial Public Offering
Sole Bookrunner

November 8, 2023
img
img
Data Knights Acquisition Corp. Merger with OneMedNet Corporation
(Nasdaq: ONMD)

~$200,000,000

Business Combination
Capital Markets Advisor

November 1, 2023
img
img
Pineapple Financial Inc.
(NYSE: PAPL)

$3,500,000

Initial Public Offering
Sole Bookrunner

October 31, 2023
img
img
American Acquisition Opportunity Inc. Merger with Royalty Management Holding Corporation
(Nasdaq: RMCO)

~$111,000,000

Business Combination
Capital Markets Advisor

October 20, 2023
img
img
Webuy Global Ltd
(Nasdaq: WBUY)

$17,480,000

Initial Public Offering
Sole Bookrunner

October 16, 2023
img
img
LQR House Inc.
(Nasdaq: LQR)

$5,400,000

Underwritten Public Offering
Sole Bookrunner

October 11, 2023
img
img
Quetta Acquisition Corporation
(Nasdaq: QETAU)

$69,000,000

SPAC IPO
Sole Bookrunner

October 2, 2023
img
img
Bruush Oral Care Inc.
(Nasdaq: BRSH)

$5,000,000

Private Placement
Exclusive Placement Agent

September 29, 2023
img
img
Estrella Biopharma, Inc. Merger with TradeUP Acquisition Corp.
()

~$325,000,000

Business Combination
Underwriter

1 6 7 8 9 10 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

img

Together, let's build meaningful value.